Cargando…

Association of a Low-Protein Diet With Slower Progression of CKD

INTRODUCTION: Reducing protein intake is recommended for slowing chronic kidney disease (CKD) progression, but assessment of its true effectiveness is sparse. METHODS: Using the Maroni formula, we assessed dietary protein intake (DPI) from 24-hour urinary urea excretion in 1594 patients (67% men and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Metzger, Marie, Yuan, Wen Lun, Haymann, Jean-Philippe, Flamant, Martin, Houillier, Pascal, Thervet, Eric, Boffa, Jean-Jacques, Vrtovsnik, François, Froissart, Marc, Bankir, Lise, Fouque, Denis, Stengel, Bénédicte
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2017
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762958/ https://www.ncbi.nlm.nih.gov/pubmed/29340320 http://dx.doi.org/10.1016/j.ekir.2017.08.010

Ejemplares similares

A 3-Marker Index Improves the Identification of Iron Disorders in CKD Anaemia
por: Mercadal, Lucile, et al.
Publicado: (2014)

The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease
por: Mercadel, Lucile, et al.
Publicado: (2014)

Decrease in Urinary Creatinine Excretion in Early Stage Chronic Kidney Disease
por: Tynkevich, Elena, et al.
Publicado: (2014)

Renal Function Can Improve at Any Stage of Chronic Kidney Disease
por: Weis, Lise, et al.
Publicado: (2013)

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease
por: Flahault, Adrien, et al.
Publicado: (2016)

Correction to: Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
por: Wagner, Sandra, et al.
Publicado: (2017)

Association of plasma potassium with mortality and end-stage kidney disease in patients with chronic kidney disease under nephrologist care - The NephroTest study
por: Wagner, Sandra, et al.
Publicado: (2017)

Extracellular Fluid Volume Is an Independent Determinant of Uncontrolled and Resistant Hypertension in Chronic Kidney Disease: A NephroTest Cohort Study
por: Vidal‐Petiot, Emmanuelle, et al.
Publicado: (2018)

Fibroblast growth factor 23 but not copeptin is independently associated with kidney failure and mortality in patients with chronic kidney disease
por: Michon-Colin, Arthur, et al.
Publicado: (2023)

Longitudinal Bone Loss Occurs at the Radius in CKD
por: Cailleaux, Pierre-Emmanuel, et al.
Publicado: (2021)

24-h Urine Collection: a Relevant Tool in CKD Nutrition Evaluation
por: Abdel-Nabey, Moustafa, et al.
Publicado: (2020)

Combining robust urine biomarkers to assess chronic kidney disease progression
por: Bienaimé, Frank, et al.
Publicado: (2023)

Urinary Sodium-to-Potassium Ratio and Blood Pressure in CKD
por: Alencar de Pinho, Natalia, et al.
Publicado: (2020)

Probiotic Intake and Inflammation in Patients With Chronic Kidney Disease: An Analysis of the CKD-REIN Cohort
por: Wagner, Sandra, et al.
Publicado: (2022)

The French Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort study
por: Stengel, Bénédicte, et al.
Publicado: (2014)

Chronic Lithium Therapy and Urine-Concentrating Ability in Individuals With Bipolar Disorder: Association Between Daily Dose and Resistance to Vasopressin and Polyuria
por: Tabibzadeh, Nahid, et al.
Publicado: (2022)

Achievement of Low-Density Lipoprotein Cholesterol Targets in CKD
por: Massy, Ziad A., et al.
Publicado: (2019)

Estimating Extracellular Fluid Volume in Healthy Individuals: Evaluation of Existing Formulae and Development of a New Equation
por: Faucon, Anne-Laure, et al.
Publicado: (2022)

The “slower” the better
por: Pala, L., et al.
Publicado: (2014)

Impact of prior CKD management in a renal care network on early outcomes in incident dialysis patients: a prospective observational study
por: Rognant, Nicolas, et al.
Publicado: (2013)

Effects of Fecal Microbiota Transplantation on Composition in Mice with CKD
por: Barba, Christophe, et al.
Publicado: (2020)

Source and Composition in Amino Acid of Dietary Proteins in the Primary Prevention and Treatment of CKD
por: Letourneau, Pierre, et al.
Publicado: (2020)

The Slower Method the Truer One
Publicado: (1896)

Rituximab in Patients With Phospholipase A2 Receptor–Associated Membranous Nephropathy and Severe CKD
por: Hanset, Nicolas, et al.
Publicado: (2019)

Worldwide Disparity in the Relation Between CKD Prevalence and Kidney Failure Risk
por: van Rijn, Marieke H.C., et al.
Publicado: (2020)

Potential Surrogate Outcomes for Kidney Failure in Advanced CKD: Evaluation of Power and Predictive Ability in CKDopps
por: Zee, Jarcy, et al.
Publicado: (2021)

What should European nephrology do with the new CKD-EPI equation?
por: Gansevoort, Ron T, et al.
Publicado: (2022)

Fatter, older and slower (and with a trigger)
por: Antonella Del Rosso
Publicado: (2013)

Slower saccadic reading in Parkinson’s disease
por: Jehangir, Naz, et al.
Publicado: (2018)

Optimizing Diet to Slow CKD Progression
por: Molina, Pablo, et al.
Publicado: (2021)

Impacts of active urea secretion into pars recta on urine concentration and urea excretion rate
por: Layton, Anita T, et al.
Publicado: (2013)

An Animal Model of Type A Cystinuria Due to Spontaneous Mutation in 129S2/SvPasCrl Mice
por: Livrozet, Marine, et al.
Publicado: (2014)

Cool down: getting further by going slower
por: Prentice, Steven
Publicado: (2007)

Human Faces Are Slower than Chimpanzee Faces
por: Burrows, Anne M., et al.
Publicado: (2014)

Half-marathoners are younger and slower than marathoners
por: Knechtle, Beat, et al.
Publicado: (2016)

Kv1 channel inactivation: Slow and slower
por: Short, Ben
Publicado: (2022)

Exome-First Strategy in Adult Patients With CKD: A Cohort Study
por: Doreille, Alice, et al.
Publicado: (2022)

Patient perspectives on chronic kidney disease and decision-making about treatment. Discourse of participants in the French CKD-REIN cohort study
por: Montalescot, Lucile, et al.
Publicado: (2022)

Less arterial stiffness in kidney transplant recipients than chronic kidney disease patients matched for renal function
por: Cheddani, Lynda, et al.
Publicado: (2020)

Safety of meglumine gadoterate (Gd-DOTA)-enhanced MRI compared to unenhanced MRI in patients with chronic kidney disease (RESCUE study)
por: Deray, Gilbert, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_mshmm9s6v3c88c23d90ns77f8u